about
High rates of loss of heterozygosity on chromosome 19p13 in human breast cancerThe pathology of familial breast cancer: Immunohistochemistry and molecular analysisDevelopment of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancerHuman growth hormone-regulated HOXA1 is a human mammary epithelial oncogenePELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinomaDetection of progesterone receptor forms A and B by immunohistochemical analysisAnalysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell linesA predictive framework for integrating disparate genomic data types using sample-specific gene set enrichment analysis and multi-task learningBis-arylidene oxindoles as anti-breast-cancer agents acting via the estrogen receptor.Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas.The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations.Estrogen regulation of TRPM8 expression in breast cancer cells.Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells.Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus.Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials.Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer's Abeta Peptide.Gene promoter methylation is associated with increased mortality among women with breast cancer.Identification of urushiols as the major active principle of the Siddha herbal medicine Semecarpus Lehyam: Anti-tumor agents for the treatment of breast cancerLong intergenic non-coding RNAs (LincRNAs) identified by RNA-seq in breast cancer.Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.Investigation of aromatase inhibitory activity of metal complexes of 8-hydroxyquinoline and uracil derivatives.Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts.The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genesERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerInterleukin-8 in breast cancer progression.Adjuvant treatment in node-negative, postmenopausal breast cancer.Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.Immunophenotypic predictive profiling of BRCA1-associated breast cancer.Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.Nonsteroidal aromatase inhibitors: recent advances.Foxo3a expression is a prognostic marker in breast cancer.Comparison and identification of estrogen-receptor related gene expression profiles in breast cancer of different ethnic originsDifferential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancerBreast imaging: A surveyClinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studiesAmplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.Aspects of molecular diagnostics and therapy in obstetrics and gynecology.Systems approaches to molecular cancer diagnostics.MicroRNA regulation of molecular pathways as a generic mechanism and as a core disease phenotype
P2860
Q24648804-59CE6388-3441-4738-9CDC-B862993A8816Q24800411-B76BE665-0BB0-486A-869E-F3C4B2EEE731Q26825584-0B091969-8B09-46E7-B372-382BA4E74194Q28217621-CA1E4D78-7E29-4280-BE8C-588E0152F03CQ28251097-34BA45A5-0F40-4F9D-9EF4-16BF854D3470Q28345003-08A585E8-85EF-40F7-9EAF-13761D8E9B0AQ28603678-CCD0716F-9FC2-4331-8ACE-74AD77EA11F8Q30571667-BDDF83AF-9BB2-483C-BF7F-2A6DF34BF2F0Q30746277-F4FFCF79-9244-470C-9549-AC56D92C2103Q33234191-DE2545A2-C096-4DD6-B64C-4DE1FD8B3735Q33495401-4E0B0E82-62C1-4905-AAE7-A040747067CAQ33581314-F4539632-3F6F-4165-8AE5-99F93DA0E05AQ33614071-50886EF3-2FC3-4C70-ADD8-477963821BFFQ33641475-59F69BB7-9931-4B3D-AFFC-597080747200Q33735001-06E67D8B-8D52-4A2D-B65A-DD5B712095CAQ33839260-5A83C178-5D33-4566-8A98-26A784163ACFQ33848807-0E8A01B2-E298-4E4D-AA65-3B2969BCB149Q33966511-DB5CAB59-DEC1-4A33-AE92-600BDA7863CFQ33988959-AEE56101-4189-4676-8D8A-E9AFCB3E8134Q34048140-BA390F80-BAF7-4F12-9FE7-F9A2F777E0ECQ34074415-19D95BDB-EB02-4BA6-BB99-8B1A747AB0A0Q34289780-58CA3309-A692-4619-926B-D977B25C25F8Q34306268-088DC7F9-8A98-4FE7-8900-B85FAC501B3EQ34334131-1CD4A23A-6B6E-4289-A105-59469722B300Q34346108-6D1C56D3-6124-445A-A210-300987EE20EAQ34385424-D83349D6-758B-46A7-B4B7-D6B64BEE7A3FQ34435827-2BA7E24A-8CB5-4FCC-9258-4CFD9979B680Q34467646-CECD164F-DB9B-4DD4-A97A-19AC1CEE6184Q34493813-9FCE884F-8D2A-45E1-A5DD-C858E8F3E17BQ34587518-7DE76C6D-0C6A-498D-AA4D-BF2B046CABB9Q34962718-B899DD94-C7C3-4887-AE27-7A329C8DDF34Q34965545-963DE55F-37E5-477B-AE97-95D85125BEDFQ34972287-C6B79E6A-CA71-48ED-AC8F-06DA7826500DQ34991926-EAC3BB84-145A-4449-BCC6-8F5F0841A101Q35000807-F1C92B6C-8368-4CB1-9480-56F7AA5673A4Q35016088-E577B34D-7649-4DA1-88CF-8D6AC27C2CDAQ35112126-C6D6B554-BE6F-4AAA-884C-AA3220DE18B2Q35142156-FA839318-E6B3-41B0-8556-5C76DC91CD24Q35162461-1D113F82-7030-4C27-B601-E512A3308FEFQ35176381-B3A83B80-DA53-43CF-85E0-F25FABCD9CE6
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Steroid hormone receptors in breast cancer management.
@ast
Steroid hormone receptors in breast cancer management.
@en
Steroid hormone receptors in breast cancer management.
@nl
type
label
Steroid hormone receptors in breast cancer management.
@ast
Steroid hormone receptors in breast cancer management.
@en
Steroid hormone receptors in breast cancer management.
@nl
prefLabel
Steroid hormone receptors in breast cancer management.
@ast
Steroid hormone receptors in breast cancer management.
@en
Steroid hormone receptors in breast cancer management.
@nl
P356
P1476
Steroid hormone receptors in breast cancer management.
@en
P2093
Osborne CK
P2888
P304
P356
10.1023/A:1006132427948
P407
P577
1998-01-01T00:00:00Z
P6179
1053618775